Functional analysis revealed that overexpression of FENDRR suppressed doxorubicin resistance, G2/M phase of cell cycle, and promoted cell apoptosis of osteosarcoma cells in vitro and tumor growth in vivo whereas FENDRR knockdown had the opposite effects. This evidence concerns the gene FENDRR and osteosarcoma.